Drug
Biphasic human insulin 30 clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Insulin aspart, insulin aspart protamine drug combination 30:70 (3) · Insulin Aspart (1) · Repaglinide (1) · Insulin, Isophane (1)
Studies
Open first, then newest update. How each study uses biphasic human insulin 30 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy JapaneseCompletedPhase 1Novo Nordisk A/SNCT01620450Written as biphasic human insulin 30
- Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT00799448Written as biphasic human insulin 30
- Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01487798Written as biphasic human insulin 30
- Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT00825253Written as biphasic human insulin 30
- Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT01526980Written as biphasic human insulin 30
- Bioequivalence of Two Mixtard® 30 Formulations in Healthy SubjectsCompletedPhase 1Novo Nordisk A/SNCT01486888Written as biphasic human insulin 30
- Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT00807092Written as biphasic human insulin 30
Given in every arm · 2 — biphasic human insulin 30 is usual care beside what is tested
- Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy VolunteersCompletedPhase 1Novo Nordisk A/SNCT01707160Written as biphasic human insulin 30
- Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT01697618Written as biphasic human insulin 30